2Kauffman RP, Baker VM, Dimarino P, et al. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations [ J ] . Am J Obstet Gynecol, 2002, 187:1362.
3曹泽毅.中华妇产科学[M].北京：人民卫生出版社,1999.2129.
4Yarali H, Yildiz B. Metformin and FSH for induction of ovulation in women with polycystic ovary syndrome [J] . Fertil steril, 1999, 72: 282.
5Pritts EA. Treatment of the infertile patient with polyeystic ovarian syndrome [J) . Obstet Gynecol Surv, 2002, 57:587.
6Nestler JE, Jakubowicz DJ, Evans WS, et al. Effects of metformin onspontaneous and ctomiphene - induced ovulation in the polycystic ovary syndrome [J]. N Engl J Med, 1998, 18:76.
8Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450clTa activity and serum free testosterone after reduction of insulin secretion in polyeystic ovary syndrome [J] . Fertil Steril, 1999, 72:985.
9Unluhizarei K, Kelestimur F, Bayram F, et al. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome [J] . Clin Endocrinol, 1999, 51 : 231.
10Glueck CJ, Wang P, Goldenberg N, et al. Pregnancy outcomes a- mong women with polycystic ovary syndrome treated with metformin [J] . Hum Reprod, 2002, 17 (11) : 2858.
二级参考文献22
1王蔼明，中华妇产科杂志，1998年，33卷，280页
2石湘芸，体液因素与临床疾病，1997年，296页
3La Marca A, MorganteG, Palumbo M, et al. Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome. Fertil Steril,2002, 78(6): 1234-1239.
4Vrbikova J, Hill M, Starka L, et al. The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polvcvstic ovary syndrome. Eur J Endocrinol, 2001, 144(6):619-628.
5Arslsnian SA, Lewy V, Danadian K, et al. Mefformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab, 2002, 87(4): 1555-1559.
6Morin-Papunen L, Vauhkonen I, Koivunen R, et al. Metformin versus ethinyl estradiol--cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study. J Clin Endocrinol Metab, 2003, 88(1)148-156.
7Kelly C J, Gordon D. The effect of metformin on hirsutism in polycystic ovary syndrome. Eur J Endocrinol, 2002, 147(2):217-221.
8fGeorge SS, George K, Irwin C, et al. Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomized, controlled trial. Hum Reprod, 2003, 18(2):299-304.
9Kocak M, Caliskan E, Simsir C, et al. Mefformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril,2002, 77(1):101-106.
10Vandermolen DT, Ratts VS, Evans WS, et al. Mefformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who axe resistant to clomiphene citrate alone. Fertil Steril, 2001, 75(2):310-315.
